Advertisement

Ads Placeholder
Loading...

Mind Cure Health Inc.

MCURFPNK
Healthcare
Biotechnology
$0.51
$0.46(971.88%)
U.S. Market opens in 4h 54m

Mind Cure Health Inc. Fundamental Analysis

Mind Cure Health Inc. (MCURF) shows weak financial fundamentals with a PE ratio of -4.65, profit margin of 0.00%, and ROE of -1.02%. The company generates N/A in annual revenue with N/A year-over-year growth of N/A.

Key Strengths

Cash Position18.31%
PEG Ratio-0.03
Current Ratio4.76

Areas of Concern

ROE-1.02%
Operating Margin0.00%
We analyze MCURF's fundamental strength across five key dimensions.

The stock receives a Fundamental Health Score of -90.3/100 based on profitability, valuation, growth, and balance sheet metrics. The F grade reflects weak fundamentals and significant financial concerns.

Fundamental Health Score

F
-90.3/100

We analyze MCURF's fundamental strength across five key dimensions:

Efficiency Score

Weak

MCURF struggles to generate sufficient returns from assets.

ROA > 10%
-1.57%

Valuation Score

Excellent

MCURF trades at attractive valuation levels.

PE < 25
-4.65
PEG Ratio < 2
-0.03

Growth Score

Weak

MCURF faces weak or negative growth trends.

Revenue Growth > 5%
N/A
EPS Growth > 10%
N/A

Financial Health Score

Excellent

MCURF maintains a strong and stable balance sheet.

Debt/Equity < 1
0.00
Current Ratio > 1
4.76

Profitability Score

Weak

MCURF struggles to sustain strong margins.

ROE > 15%
-102.08%
Net Margin ≥ 15%
0.00%
Positive Free Cash Flow
No

Key Financial Metrics

Is MCURF Expensive or Cheap?

P/E Ratio

MCURF trades at -4.65 times earnings. This suggests potential undervaluation.

-4.65

PEG Ratio

When adjusting for growth, MCURF's PEG of -0.03 indicates potential undervaluation.

-0.03

Price to Book

The market values Mind Cure Health Inc. at 9.26 times its book value. This suggests the stock is fully valued or overvalued on an asset basis.

9.26

EV/EBITDA

Enterprise value stands at -21.80 times EBITDA. This is generally considered low.

-21.80

How Well Does MCURF Make Money?

Net Profit Margin

For every $100 in sales, Mind Cure Health Inc. keeps $0.00 as profit after all expenses.

0.00%

Operating Margin

Core operations generate 0.00 in profit for every $100 in revenue, before interest and taxes.

0.00%

ROE

Management delivers $-1.02 in profit for every $100 of shareholder equity.

-1.02%

ROA

Mind Cure Health Inc. generates $-1.57 in profit for every $100 in assets, demonstrating efficient asset deployment.

-1.57%

Following the Money - Real Cash Generation

FCF Per Share

Each share generates $-0.10 in free cash annually.

$-0.10

FCF Yield

MCURF converts -8.23% of its market value into free cash.

-8.23%

Financial Ratios Analysis

Valuation Ratios

P/E Ratio

Price to earnings ratio

-4.65

vs 25 benchmark

PEG Ratio

Price/earnings to growth ratio

-0.03

vs 25 benchmark

P/B Ratio

Price to book value ratio

9.26

vs 25 benchmark

P/S Ratio

Price to sales ratio

0.00

vs 25 benchmark

Financial Health

Debt/Equity

Total debt to shareholders' equity

0.00

vs 25 benchmark

Current Ratio

Current assets to current liabilities

4.76

vs 25 benchmark

Efficiency Ratios

ROE

Return on equity percentage

-1.02

vs 25 benchmark

ROA

Return on assets percentage

-1.57

vs 25 benchmark

ROCE

Return on capital employed

-0.83

vs 25 benchmark

How MCURF Stacks Against Its Sector Peers

MetricMCURF ValueSector AveragePerformance
P/E Ratio-4.6528.23 Better (Cheaper)
ROE-102.08%737.00% Weak
Net Margin0.00%-46175.00% (disorted) Weak
Debt/Equity0.000.35 Strong (Low Leverage)
Current Ratio4.764.10 Strong Liquidity
ROA-157.29%-17785.00% (disorted) Weak

MCURF outperforms its industry in 3 out of 6 key metrics, but lagging in ROE.

Historical Growth Performance

5-Year Growth Trajectory

This section reviews Mind Cure Health Inc.'s 5-year compound annual growth rate (CAGR) and compares its performance against the typical investment style of its industry.

Revenue CAGR

N/A

Industry Style: Defensive, Growth, Innovation

EPS CAGR

N/A

Industry Style: Defensive, Growth, Innovation

FCF CAGR

N/A

Industry Style: Defensive, Growth, Innovation

Fundamental Analysis FAQ